2013 EHA: Outcomes of intermediate or high risk MDS patients post azacitidine and or decitabine 25 May 2013/in Uncategorised /by webadmin2013 EHA: Outcomes of intermediate or high risk MDS patients post azacitidine and or decitabine /wp-content/uploads/2019/11/logo_white.png 0 0 webadmin /wp-content/uploads/2019/11/logo_white.png webadmin2013-05-25 15:55:112016-12-01 12:45:502013 EHA: Outcomes of intermediate or high risk MDS patients post azacitidine and or decitabine
